Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Exchange Rate Effect (2018 - 2025)

Autolus Therapeutics (AUTL) has disclosed Exchange Rate Effect for 5 consecutive years, with -$3.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Exchange Rate Effect fell 109.5% year-over-year to -$3.6 million, compared with a TTM value of -$32.5 million through Sep 2025, down 168.15%, and an annual FY2024 reading of -$261000.0, down 101.74% over the prior year.
  • Exchange Rate Effect was -$3.6 million for Q3 2025 at Autolus Therapeutics, down from $5.7 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $37.7 million in Q3 2024 and bottomed at -$38.2 million in Q4 2024.
  • Average Exchange Rate Effect over 4 years is $2.6 million, with a median of $4.6 million recorded in 2025.
  • Peak annual rise in Exchange Rate Effect hit 505.57% in 2024, while the deepest fall reached 491.04% in 2024.
  • Year by year, Exchange Rate Effect stood at $11.1 million in 2022, then decreased by 11.82% to $9.8 million in 2023, then tumbled by 491.04% to -$38.2 million in 2024, then skyrocketed by 90.62% to -$3.6 million in 2025.
  • Business Quant data shows Exchange Rate Effect for AUTL at -$3.6 million in Q3 2025, $5.7 million in Q2 2025, and $3.6 million in Q1 2025.